Barclays
PRNB

Barclays’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Barclays’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-18,808
Closed -$1.12M – 5813
2020
Q2 		$1.12M Sell
18,808
-3,647
-16% -$225K ﹤0.01% 2652
2020
Q1 		$1.33M Sell
22,455
-953
-4% -$55.6K ﹤0.01% 2670
2019
Q4 		$1.28M Buy
23,408
+13,162
+128% +$491K ﹤0.01% 3447
2019
Q3 		$288K Sell
10,246
-34
-0.3% -$1.25K ﹤0.01% 4693
2019
Q2 		$342K Sell
10,280
-4,220
-29% -$132K ﹤0.01% 4667
2019
Q1 		$493K Buy
14,500
+13,288
+1,096% +$423K ﹤0.01% 4139
2018
Q4 		$33K Sell
1,212
-43
-3% -$1.11K ﹤0.01% 5692
2018
Q3 		$37K Buy
+1,255
New +$35.4K ﹤0.01% 6240

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Barclays's PRNB Position: Q3 2020 in Review

Barclays sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 18,808 shares — an estimated $1.12M sold.

Barclays first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $1.33M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Barclays reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Barclays sold 18,808 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $1.12M.
  • Barclays first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Barclays's Principia Biopharma Inc. Common Stock position peaked at $1.33M in Q1 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.